Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the infuse-Ami trial)

American Journal of Cardiology

Volumn 115, Issue 5, 2015, Pages 563-570

  Dohi, Tomotaka ^a,b   Maehara, Akiko ^a,b   Brener, Sorin J ^b,c   Généreux, Philippe ^a,b,d   Gershlick, Anthony H ^e   Mehran, Roxana ^b,f   Gibson, C Michael ^g   Mintz, Gary S ^b   Stone, Gregg W ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c NEW YORK METHODIST HOSPITAL   (United States)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^e GLENFIELD HOSPITAL   (United Kingdom)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; CREATINE KINASE MB; HIRULOG; TROPONIN I; TROPONIN T; ANTICOAGULANT AGENT; HIRUDIN DERIVATIVE; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ASPIRATION CATHETER; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART STROKE VOLUME; HUMAN; HYPERLIPIDEMIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL INFUSION CATHETER; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS ASPIRATION; ANTERIOR WALL MYOCARDIAL INFARCTION; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; ETIOLOGY; HEART LEFT VENTRICLE FUNCTION; MULTICENTER STUDY; PATHOLOGY; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; THROMBECTOMY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTERIOR WALL MYOCARDIAL INFARCTION; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; CREATINE KINASE, MB FORM; FEMALE; HIRUDINS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; PEPTIDE FRAGMENTS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; STROKE VOLUME; THROMBECTOMY; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84923031514     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.12.008     Document Type: Article

References (24)

1. R.J. Burns, R.J. Gibbons, Q. Yi, R.S. Roberts, T.D. Miller, G.L. Schaer, J.L. Anderson, and S. Yusuf The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis J Am Coll Cardiol 39 2002 30 36
2. R.J. Gibbons, U.S. Valeti, P.A. Araoz, and A.S. Jaffe The quantification of infarct size J Am Coll Cardiol 44 2004 1533 1542
3. C.T. Chin, T.Y. Wang, S. Li, S.D. Wiviott, J.A. deLemos, M.C. Kontos, E.D. Peterson, and M.T. Roe Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines Clin Cardiol 35 2012 424 429
4. D.J. Pennell Cardiovascular magnetic resonance Circulation 121 2010 692 705
5. H. Mahrholdt, A. Wagner, T.A. Holly, M.D. Elliott, R.O. Bonow, R.J. Kim, and R.M. Judd Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging Circulation 106 2002 2322 2327
6. R.J. Kim, T.S. Albert, J.H. Wible, M.D. Elliott, J.C. Allen, J.C. Lee, M. Parker, A. Napoli, and R.M. Judd Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial Circulation 117 2008 629 637
7. E. Hedstrom, K. Astrom-Olsson, H. Ohlin, F. Frogner, M. Carlsson, T. Billgren, S. Jovinge, P. Cain, G.S. Wagner, and H. Arheden Peak CKMB and cTnT accurately estimates myocardial infarct size after reperfusion Scand Cardiovasc J 41 2007 44 50
8. E. Giannitsis, H. Steen, K. Kurz, B. Ivandic, A.C. Simon, S. Futterer, C. Schild, P. Isfort, A.S. Jaffe, and H.A. Katus Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T J Am Coll Cardiol 51 2008 307 314
9. J. Hallen, J.K. Jensen, M.W. Fagerland, A.S. Jaffe, and D. Atar Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction Heart 96 2010 1892 1897
10. G. Klug, A. Mayr, J. Mair, M. Schocke, M. Nocker, T. Trieb, W. Jaschke, O. Pachinger, and B. Metzler Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI Clin Res Cardiol 100 2011 501 510
11. C.M. Gibson, A. Maehara, A.J. Lansky, J. Wohrle, T. Stuckey, R. Dave, D. Cox, C. Grines, D. Dudek, G. Steg, H. Parise, S.D. Wolff, E. Cristea, and G.W. Stone Rationale and design of the INFUSE-AMI study: a 2 x 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction Am Heart J 161 2011 478 486.e7
12. G.W. Stone, A. Maehara, B. Witzenbichler, J. Godlewski, H. Parise, J.H. Dambrink, A. Ochala, T.W. Carlton, E. Cristea, S.D. Wolff, S.J. Brener, S. Chowdhary, M. El-Omar, T. Neunteufl, D.C. Metzger, T. Karwoski, J.M. Dizon, R. Mehran, and C.M. Gibson Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial JAMA 307 2012 1817 1826
13. A.W. van 't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, and F. Zijlstra Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group Circulation 97 1998 2302 2306
14. R. Schroder, K. Wegscheider, K. Schroder, R. Dissmann, and W. Meyer-Sabellek Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial J Am Coll Cardiol 26 1995 1657 1664
15. C.W. Yancy, M. Lopatin, L.W. Stevenson, T. De Marco, and G.C. Fonarow Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database J Am Coll Cardiol 47 2006 76 84
16. G.C. Fonarow, W.G. Stough, W.T. Abraham, N.M. Albert, M. Gheorghiade, B.H. Greenberg, C.M. O'Connor, J.L. Sun, C.W. Yancy, and J.B. Young Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777
17. C.M. Gibson, C.P. Cannon, S.A. Murphy, S.J. Marble, H.V. Barron, and E. Braunwald Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction Circulation 105 2002 1909 1913
18. D.E. Kandzari, J.E. Tcheng, B.J. Gersh, D.A. Cox, T. Stuckey, M. Turco, R. Mehran, E. Garcia, P. Zimetbaum, M.G. McGlaughlin, A.J. Lansky, C.O. Costantini, C.L. Grines, and G.W. Stone Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction Am Heart J 151 2006 1288 1295
19. J. Karha, S.A. Murphy, A.J. Kirtane, J.A. de Lemos, J.M. Aroesty, C.P. Cannon, E.M. Antman, E. Braunwald, and C.M. Gibson Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction Am J Cardiol 92 2003 913 918
20. A. Halkin, G.W. Stone, C.L. Grines, D.A. Cox, B.D. Rutherford, P. Esente, C.M. Meils, P. Albertsson, A. Farah, J.E. Tcheng, A.J. Lansky, and R. Mehran Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction J Am Coll Cardiol 47 2006 951 961
21. J.N. Cohn, R. Ferrari, and N. Sharpe Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling J Am Coll Cardiol 35 2000 569 582
22. H. Engblom, E. Hedstrom, E. Heiberg, G.S. Wagner, O. Pahlm, and H. Arheden Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: one-year follow-up by MRI Circ Cardiovasc Imaging 2 2009 47 55
23. M.A. Pfeffer, and E. Braunwald Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 81 1990 1161 1172
24. S.D. Solomon, R.J. Glynn, S. Greaves, U. Ajani, J.L. Rouleau, F. Menapace, J.M. Arnold, C. Hennekens, and M.A. Pfeffer Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study Ann Intern Med 134 2001 451 458